Mr Learner, there has been no improvement from management yet the product is speaking for itself.I have no doubts in the near future it will spike but that is not what we are here for.It needs consistency and well written reports to substantiate the SP going forward.I trust you are well at the moment and stay safe.
- Forums
- ASX - By Stock
- PER
- Ann: ANP Submits US Orphan Drug application for ATL1102 in DMD
Ann: ANP Submits US Orphan Drug application for ATL1102 in DMD, page-61
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $75.73M |
Open | High | Low | Value | Volume |
8.4¢ | 8.4¢ | 8.4¢ | $18.06K | 215K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 18130 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 240131 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 18130 | 0.085 |
2 | 306394 | 0.084 |
1 | 10000 | 0.083 |
2 | 193598 | 0.082 |
2 | 49037 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 240131 | 5 |
0.088 | 13868 | 1 |
0.089 | 14285 | 1 |
0.090 | 546175 | 2 |
0.091 | 108000 | 1 |
Last trade - 10.54am 19/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Don Currie, CEO
Don Currie
CEO
Previous Video
Next Video
SPONSORED BY The Market Online